Retinis Pigmentosa Market is driven by Gene Therapy Advances
The Retinis Pigmentosa market encompasses innovative gene therapies, pharmacological treatments, and advanced diagnostic tools designed to halt or reverse degeneration of the retina in patients with inherited retinal dystrophies. Retinis Pigmentosa Market Gene therapy vectors, such as adeno-associated viruses, deliver corrective genes directly to photoreceptor cells, offering targeted...
0 Comments 0 Shares 6 Views 0 Reviews
Sponsored